|
KMID : 1148920120460020129
|
|
Nuclear Medicine and Molecular Imaging
2012 Volume.46 No. 2 p.129 ~ p.133
|
|
|
Ga-68 Somatostatin Receptor PET/CT in von Hippel-Lindau Disease
|
|
Oh Jong-Ryool
Kulkarni Harshad
Carreras Cecilia
Schalch Georg
Min Jung-Joon
Baum Richard P.
|
|
|
Abstract
|
|
|
|
Von Hippel-Lindau (VHL) disease is a dominantly inherited familial cancer syndrome with a variety of benign and malignant tumors such as retinal and central nervous system hemangioblastomas, endolymphatic sac tumors, renal cysts and tumors, pancreatic cysts and tumors, pheochromocytomas, and epididymal cystadenomas. Cross-sectional modalities (computed tomography and magnetic resonance imaging) as well as ultrasound play a major role in the initial evaluation and follow-up of the various manifestations of VHL disease. Ga-68-labeled somatostatin receptor analogs already have a significant role in the diagnosis, staging, and therapy management of neuroendocrine neoplasms and neural crest tumors. Herein, we report a case presenting a variety of malignancies in VHL and showing the usefulness of Ga-68 somatostatin receptor PET/CT as a one-stop-shop imaging modality in the management of VHL disease.
|
|
|
KEYWORD
|
|
|
Ga-68 DOTA-TOC PET/CT, Ga-68 DOTA-TATE PET/CT, Ga-68 DOTA-NOC PET/CT von Hippel-Lindau disease, Hemangioblastoma, Pheochromocytoma
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|